Clinical trial
Characterization of Dermal Reactions in Pediatric Patients With ADHD Using…
NCT00434213 · Noven Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00434213 |
|---|---|
| Title | Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA |
| Official title | A Phase IV, Multi-center, Open-label Study of DAYTRANA (Methylphenidate Transdermal System [MTS]) to Characterize the Dermal Reactions in Pediatric Patients Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD). |
| Lead sponsor | Noven Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Daytrana |
| Enrollment | 309 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Feb 13, 2007 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: